1. The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA.
- Author
-
Taniguchi I
- Subjects
- Animals, Humans, Viral Proteins metabolism, Viral Proteins genetics, COVID-19 virology, COVID-19 metabolism, Nuclear Matrix-Associated Proteins metabolism, Nuclear Matrix-Associated Proteins genetics, Xenopus laevis, Oocytes metabolism, Oocytes virology, Active Transport, Cell Nucleus, RNA, Messenger genetics, RNA, Messenger metabolism, SARS-CoV-2 metabolism, SARS-CoV-2 genetics, Spliceosomes metabolism, RNA, Small Nuclear metabolism, RNA, Small Nuclear genetics, Nucleocytoplasmic Transport Proteins metabolism, Nucleocytoplasmic Transport Proteins genetics
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19). SARS-CoV-2 infection suppresses host innate immunity and impairs cell viability. Among the viral proteins, ORF6 exhibits potent interferon (IFN) antagonistic activity and cellular toxicity. It also interacts with the RNA export factor RAE1, which bridges the nuclear pore complex and nuclear export receptors, suggesting an effect on RNA export. Using the Xenopus oocyte microinjection system, I found that ORF6 blocked the export of not only mRNA but also spliceosomal U snRNA. I further demonstrated that ORF6 affects the interaction between RAE1 and nuclear export receptors and inhibits the RNA binding of RAE1. These effects of ORF6 may cumulatively block the export of several classes of RNA. I also found that ORF6 binds RNA and forms oligomers. These findings provide insights into the suppression of innate immune responses and the reduction in cell viability caused by SARS-CoV-2 infection, contributing to the development of antiviral drugs targeting ORF6., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2024 Ichiro Taniguchi. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF